Displaying 1–25 of 25 results for Bill Swichtenberg, Senior Editor
Pharmaceutical Manufacturings Salary and Job Satisfaction Survey reveals that the industry might be experiencing some type of a rebirth based on new ways of doing business. Efficiency, flexibility and a love for what you do are key elements to combat cost reductions and other challenges taking...
Walter Henslee of Dow Chemical discusses the importance of human interaction with process analyzers in PAT.
If you can design quality into a new product and make it better, why cant you use data to re-engineer a legacy product and continuously improve its quality? These are the questions that Line Lundsberg-Nielsen, a consultant at NNE Pharmaplan (Surrey, UK) addressed in her presentation at the IFPAC...
A relative whos who in the world of Process Analytical Technology (PAT) gathered for a roundtable discussion at an IFPAC pre-conference on Sunday in Baltimore, Maryland.
Cost savings, FDA endorsement and the willingness of drug manufacturers to collaborate to find new methods might facilitate the move to continuous processing.
Managers might be expecting the wrong near-term results when it comes to the benefits of lean manufacturing, resulting in apathy. A recent lean production survey conducted by Lean Enterprise Institute (LEI) found that cutting costs was rated as the top benefit to the process by managers and ...
This year's Team of the Year finalists are collaborating with partners, opening dialogue between FDA and industry and improving process understanding at their facilities.
Controlling microbiological contamination is an ongoing process laden with risks. The best weapon against biofilm is prevention.
While it may seem that pharmaceutical manufacturers are bitter enemies on the competitive battleground, it turns out that most of them have the same problems and concerns and are willing to help one another if possible. This was the message from the BIO conference session, Management of Global, ...
Expensive and fragile biologics, longer shelf-life and storage requirements and user-friendly demands are shaping the filling process.
Isolators have allowed Bayer Healthcares Shawnee, Kansas facility to run for three years without a single false positive.
Operational excellence requires a deep commitment and a culture of change. A recent survey shows where pharmaceutical manufacturers stand on the path.
After years of testing, some manufacturers are applying new technologies to thwart drug counterfeiters and ensure a safe supply chain.
Sustainability not only feels good, it pays off, as a growing number of drug companies are learning.
Couldnt make the trip to Chicago? The weather outside was frightful, but the technology was cutting edge. Pharmaceutical Manufacturings editors take a look at who and what was at this years conference.
Addressing misconceptions, fostering a culture of compliance and patient-focused behavior and refocusing sales and marketing activities can restore and strengthen the industry, says a report from PricewaterhouseCoopers.
A collaborative way to exchange document-based pedigrees for pharmaceuticals and other industries has been ratified. GS1 EPCglobal, the not-for-profit standards organization dedicated to driving global adoption of the Electronic Product Code (EPC) for supply chains, has announced the approval of ...
Mitigating risks is a balance between the costs of applying security measures and the likelihood of an incident.
The U.S. Pharmacopeia's program is designed to assure manufacturers, regulatory authorities and consumers that drug substances and excipients bearing the USP Program Mark are of consistent, high quality.
The Hot Topic session on dissolution testing at the recent AAPS Annual Meeting put PAT expert Ajaz Hussain on the hot seat in a debate over the applicability of a "testing tablet" to determining the stability of a solid dosage form.